共 123 条
[1]
Bailie GR(2004)Calcium and phosphorus management in chronic kidney disease: challenges and trends Formulary 39 358-65
[2]
Hutchison AJ(2004)Improving phosphate-binder therapy as a way forward Nephrol Dial Transplant 19 i19-24
[3]
Qunibi WY(2004)Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD) Kidney Int Suppl 66 S8-12
[4]
Block GA(2004)Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 2208-18
[5]
Klassen PS(2005)Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study Kidney Int 67 1179-87
[6]
Lazarus JM(2003)K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis 42 S1-201
[7]
Young EW(2004)A comparison of clinically useful phosphorus binders for patients with chronic kidney failure Kidney Int Suppl 66 S25-32
[8]
Albert JM(2004)Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? Kidney Int 66 1315-33
[9]
Satayathum S(2004)Factors for increased morbidity and mortality in uremia: hyperphosphatemia Semin Nephrol 24 396-400
[10]
Emmett M(2004)The role of sevelamer in achieving the kidney disease outcomes quality initiative (K/ DOQI) guidelines for hyperphosphatemia Curr Med Res Opin 20 991-9